Lymphoma News
FDA Approves Ibrutinib to Treat Chronic Graft Versus Host Disease
New York, NY (August 3, 2017) – New York, NY – The U.S. Food and Drug Administration (FDA) announced it has approved the use of
Read More >
New York, NY (August 3, 2017) – New York, NY – The U.S. Food and Drug Administration (FDA) announced it has approved the use of
Read More >New York, NY (June 5, 2017) – The U.S. Food and Drug Administration (FDA) announced it has approved the use of subcutaneous rituximab (Rituxan ®)
Read More >New York, NY (March 14, 2017) – The U.S. Food and Drug Administration (FDA) announced it has approved the use of pembrolizumab (KEYTRUDA ®) to
Read More >
Lymphoma Research Foundation publishes White Paper to outline key issues discussed during Oral Therapies workshop In September 2015, The Lymphoma Research Foundation (LRF) convened scientists,
Read More >
